|
ZNF611 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62558855265615E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.67912383786506E-12 |
| Normal-vs-Stage2 |
1.98670000006729E-07 |
| Normal-vs-Stage3 |
2.16715534406831E-12 |
| Normal-vs-Stage4 |
2.26785257240181E-12 |
| Stage1-vs-Stage2 |
8.829400E-01 |
| Stage1-vs-Stage3 |
1.812820E-01 |
| Stage1-vs-Stage4 |
3.341100E-03 |
| Stage2-vs-Stage3 |
4.305600E-01 |
| Stage2-vs-Stage4 |
6.334300E-02 |
| Stage3-vs-Stage4 |
1.541550E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.5043083686287E-14 |
| Normal-vs-AfricanAmerican |
1.040710E-04 |
| Normal-vs-Asian |
3.40879999782828E-08 |
| Caucasian-vs-AfricanAmerican |
4.597400E-01 |
| Caucasian-vs-Asian |
9.037200E-01 |
| AfricanAmerican-vs-Asian |
4.421800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.53574938824386E-13 |
| Normal-vs-Female |
1.69264602334351E-12 |
| Male-vs-Female |
5.681600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.09480219229386E-11 |
| Normal-vs-Age(41-60Yrs) |
5.97966121063109E-13 |
| Normal-vs-Age(61-80Yrs) |
2.22990514942012E-11 |
| Normal-vs-Age(81-100Yrs) |
1.904450E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.661190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.066600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.256600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.464200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.812400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.189000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.560000E-02 |
| Classical-VS-Follicular |
5.778400E-01 |
| Classical-VS-Other |
1.442400E-01 |
| Classical-VS-Normal |
3.81020004436294E-09 |
| Tall-VS-Follicular |
2.296600E-01 |
| Tall-VS-Other |
5.536200E-01 |
| Tall-VS-Normal |
4.05590006025136E-10 |
| Follicular-VS-Other |
3.734400E-01 |
| Follicular-VS-Normal |
5.02179999806174E-08 |
| Other-VS-Normal |
4.786200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53210777398272E-14 |
| Normal-vs-N1 |
1.74470005109839E-09 |
| N0-vs-N1 |
4.686000E-01 |
|
|
